Harpoon Therapeutics (HARP) Stock Highlights

23.01 | +0%

2024-12-21 05:27:51

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases. The companys pipeline products include HPN424, HPN536, HPN217, and others.

Statistics

Range Today

23.01 23.01

Volume Today 0

Range 1 Year

0.54 23.21

Volume 1 Year 108.13M

Range 3 Year

0.54 24.2

Volume 3 Year 380.54M

Range 10 Year

0.54 25.235

Volume 10 Year 458.11M

Highlights

Market Capitalization 492.35M (small)

Floating Shares 10.15M

Current Price 23.01

Price To Earnings -2.67

Price To Revenue 10.21

Price To Book 20.82

Earnings Per Share -8.62

Payout Ratio 0%

Performance

Latest 0%

1 Month +2.72%

3 Months +160.59%

6 Months +195.38%

1 Year +3495.31%

3 Years +17.76%

5 Years +72.36%

10 Years +64.36%

Benchmarks

Market Capitalization

172 / 368

Gross Profits

197 / 278

Total Revenue

136 / 300

Total Rank

142 / 368

Free Cashflow

230 / 352

Performance 5 years

70 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.